Literature DB >> 23475503

Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.

K V Rolston1, L Nesher, V Mulanovich, R Chemaly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23475503     DOI： 10.1007/s15010-013-0434-y

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  6 in total

1.  Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.

Authors:  B J Liss; J J Vehreschild; O A Cornely; M Hallek; G Fätkenheuer; H Wisplinghoff; H Seifert; M J G T Vehreschild
Journal:  Infection       Date:  2012-06-05       Impact factor: 3.553

2.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

3.  Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.

Authors:  Madonna J Matar; Jeffrey Tarrand; Issam Raad; Kenneth V I Rolston
Journal:  Am J Infect Control       Date:  2006-10       Impact factor: 2.918

4.  Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer.

Authors:  Norio Ohmagari; Hend Hanna; Linda Graviss; Brenda Hackett; Cheryl Perego; Virginia Gonzalez; Tanya Dvorak; Holly Hogan; Ray Hachem; Kenneth Rolston; Issam Raad
Journal:  Cancer       Date:  2005-07-01       Impact factor: 6.860

5.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

6.  Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer.

Authors:  Shoaib R Ansari; Hend Hanna; Ray Hachem; Ying Jiang; Kenneth Rolston; Issam Raad
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860
  6 in total
  1 in total

1.  Incidence of genes encoding vanA/vanB vancomycin resistance in rectal swabs of patients with diagnosed cancer, on the day of admission to hospital, in a non-epidemic period.

Authors:  Maria Szymankiewicz; Joanna Wróblewska; Tomasz Nowikiewicz
Journal:  Prz Gastroenterol       Date:  2020-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.